Anat Globerson Levin

Years Active: 2022-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Gil Fridberg, Galit Horn, Anat Globerson Levin, Dan Benisty, Sigi Kay, Chen Glait-Santar, Chava Perry, Ron Ram, Irit Avivi, Ben-Zion Katz
The Clinical Significance of Circulating Lymphocytes Morphology in Diffuse Large B-Cell Lymphoma As Determined by a Novel, Highly Sensitive Microscopy. Cancers 15 (23) (2023)
Julia Sajman, Oren Yakovian, Naamit Unger Deshet, Shaked Almog, Galit Horn, Tova Waks, Anat Globerson Levin, Eilon Sherman
Nanoscale CAR Organization at the Immune Synapse Correlates with CAR-T Effector Functions. Cells 12 (18) (2023)
Anat Aharon, Galit Horn, Tali Hana Bar-Lev, Einav Zagagi Yohay, Tova Waks, Maya Levin, Naamit Deshet Unger, Irit Avivi, Anat Globerson Levin
Extracellular Vesicles Derived from Chimeric Antigen Receptor-T Cells: A Potential Therapy for Cancer. Human gene therapy 32 (19-20) (2022)
Naamit Deshet-Unger, Galit Horn, Moran Rawet-Slobodkin, Tova Waks, Ido Laskov, Nadav Michaan, Yael Raz, Vered Bar, Adi Zundelevich, Sara Aharon, Lubov Turovsky, Giuseppe Mallel, Seth Salpeter, Guy Neev, Kenneth Samuel Hollander, Ben-Zion Katz, Dan Grisaru, Anat Globerson Levin
Comparing Intraperitoneal and Intravenous Personalized ErbB2CAR-T for the Treatment of Epithelial Ovarian Cancer. Biomedicines 10 (9) (2022)

Anat Globerson Levin.css-eqlu8i{font-size:small;padding-left:4px;}